期刊文献+

厄贝沙坦联合针灸治疗原发性高血压的临床疗效探究 被引量:2

Exploration on the Clinical Efficacy of Irbesartan Combined with Acupuncture and Moxibustion in the Treatment of Essential Hypertension
下载PDF
导出
摘要 目的探究原发性高血压患者使用厄贝沙坦联合针灸治疗的临床效果。方法将2016年12月—2019年8月接收的220例原发性高血压患者按照治疗方式中是否采取中医针灸治疗分为联合组与参照组,每组110例,参照组采用厄贝沙坦,联合组则在参照组的基础上采取中医针灸治疗,对比两组治疗后的血压、不良反应,总结各组的疗效。结果联合组治疗后的SBP(129.68±6.54)、DBP(70.65±8.02)mmHg与参照组(145.38±8.43)、(83.65±6.95)mmHg比较,组间差异有统计学意义(t=8.507、8.019,P=0.021、0.024);两组的心率差异无统计学意义(t=0.842,P=0.949);联合组的总疗效92.73%与参照组67.27%比较,组间差异有统计学意义(χ^2=19.346,P=0.007);联合组出现头晕、头痛、咳嗽等不良反应的发生率4.55%与参照组6.63%差异无统计学意义(χ^2=1.015,P=0.896)。结论对于原发性高血压患者,临床上采取厄贝沙坦联合针灸治疗方式,其疗效更加显著,值得临床推广应用。 Objective To explore the clinical effects of irbesartan combined with acupuncture treatment in patients with essential hypertension.Methods 220 patients with essential hypertension received from December 2016 to August 2019 were divided into a combination group and a reference group of 110 patients according to whether they were treated with traditional Chinese medicine acupuncture and moxibustion.The reference group was treated with irbesartan and combined group took TCM acupuncture treatment on the basis of the reference group,compared the blood pressure and adverse reactions of the two groups after treatment,and summarized the curative effect of each group.Results The SBP(129.68±6.54)mmHg and DBP(70.65±8.02)mmHg of the combined group after treatment were compared with the reference group(145.38±8.43)mmHg and(83.65±6.95)mmHg.The difference between the groups was statistically significant(t=8.507,8.019,P=0.021,0.024);the heart rate difference between the two groups was not statistically significant(t=0.842,P=0.949);the total curative effect of the combination group was 92.73%compared with the reference group 67.27%,the difference between the groups was statistically significant(χ^2=19.346,P=0.007);The incidence of dizziness,headache,cough and other adverse reactions in the combination group was 4.55%and 6.63%in the reference group,the difference was not statistically significant(χ^2=1.015,P=0.896).Conclusion For patients with essential hypertension,irbesartan combined with acupuncture treatment is clinically more effective and worthy of clinical application.
作者 杨松 帅列 YANG Song;SHUAI Lie(Department of Rehabilitation,Hospital of Traditional Chinese Medicine,Dadukou District,Chongqing,400082 China;Department of Internal Medicine,Dadukou District Hospital of Traditional Chinese Medicine,Chongqing,400082,China)
出处 《系统医学》 2020年第20期131-133,共3页 Systems Medicine
关键词 厄贝沙坦 针灸 原发性高血压 临床疗效 Irbesartan Acupuncture Essential hypertension Clinical efficacy
  • 相关文献

参考文献10

二级参考文献64

  • 1漆满英,肖建纲,吴晓昇.厄贝沙坦治疗原发性高血压疗效观察[J].实用中西医结合临床,2004,4(6):40-40. 被引量:4
  • 2陈江斌,王晋明,王芳,江洪,李建军,王跃岭,蒋学俊,杨波,李晓艳.厄贝沙坦和依那普利治疗原发性高血压的对比研究[J].临床内科杂志,2005,22(6):384-386. 被引量:8
  • 3常素英,季成叶.我国学龄儿童青少年血压与超重和肥胖的相关性研究[J].中国学校卫生,2006,27(8):652-653. 被引量:39
  • 4刘锐锋.厄贝沙坦治疗轻、中度高血压有效性与安全性的Meta分析[J].广东药学院学报,2006,22(6):647-650. 被引量:7
  • 5蔡文花.厄贝沙坦与依那普利治疗原发性轻中度高血压的比较[J].河北医学,2007,13(11):1350-1351. 被引量:12
  • 6PETERS CD,KJ RGAARD KD,JESPERSEN B,et al.Renal and cardiovascular effects of irbesartan in dialysis patients-a randomized controlled trial protocol (SAFIR study). Dan Med J . 2013
  • 7Nakamura M,Sasai N,Hisatome I,et al.Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes. Clinical Pharmacology . 2014
  • 8Ciaran J. McMullan,Hiddo J. Lambers Heerspink,Hans-Henrik Parving,Jamie P. Dwyer,John P. Forman,Dick de Zeeuw.??Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial(J)American Journal of Kidney Diseases . 2014 (5)
  • 9Andrea Hartner,Nada Cordasic,Bernd Klanke,Carlos Menendez-Castro,Roland Veelken,Roland E. Schmieder,Karl F. Hilgers.??Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress(J)BBA - Molecular Basis of Disease . 2014 (4)
  • 10Krista Dybtved Kjaergaard,Christian Daugaard Peters,Bente Jespersen,Ida N?rager Tietze,Jens Kristian Madsen,Birgitte Bang Pedersen,Marija Kristina Novosel,Kathrine Skaaning Laursen,Bo Martin Bibby,Charlotte Strandhave,Jens Dam Jensen.??Angiotensin Blockade and Progressive Loss of Kidney Function in Hemodialysis Patients: A Randomized Controlled Trial(J)American Journal of Kidney Diseases . 2014

共引文献55

同被引文献26

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部